Mozifor 24 mg Injection
Mozifor 24 mg Injection
Prescription Required
Prescription Required

Mozifor 24 mg Injection | 1.2 ml 1 Vial

You Save ₹ 19505.00
(Inclusive of all taxes)
45% OFF
Hetero Healthcare Ltd
Plerixafor 24 mg

Introduction of Mozifor Injection

Mozifor 24 mg Injection is an immunostimulant used in cancer patients, It mobilizes hematopoietic stem cells into blood stream. The chemical formula of this molecule is C28H54N8. It is also known as a Hematopoietic stem cell mobilized. Mozifor 24 mg Injection causes blood cells to move from the bone marrow towards blood so they can be extracted for transplant

Uses of Mozifor Injection

  • Non Hodgkin's lymphoma
  • Multiple Myeloma

Benefits of Mozifor Injection

Mozifor 24 mg Injection is used as a peripheral blood stem cell mobilization, which is a very useful source of hematopoietic stem cells for transplantation.

Side Effects of Mozifor Injection

  • Burning
  • Crawling
  • Itching
  • Numbness
  • Vomiting
  • Headache

Most Common Side Effects of Mozifor Injection

  • Constipation
  • Nausea
  • Dry mouth
  • Numbness
  • Stomach upset
  • Bloating
  • Lethargic
  • Muscle pain
  • Profuse perspiration
  • Rashes
  • Irritation

Common Side Effects of Mozifor Injection

  • Bleeding
  • Unusual weakness
  • Severe epigastric pain
  • Joint pain
  • Dizziness

How to Use Mozifor Injection?

Mozifor 24 mg Injection is available as an injectable form that must be administered under the skin ( subcutaneously) as directed by your doctor under medical supervision only. Mozifor 24 mg Injection is usually given 11 hours prior to blood filtering procedure. Dosage and frequency will be decided by your doctor as per your medical condition and weight and certain other factors.

How Mozifor Injection Works?

Mozifor 24 mg Injection is an inhibitor of the CXCR4 chemokine receptor and blocks the binding of its cognate ligand, SDF- 1 alfa. Once in the marrow, stem cell CXCR 4 can act to help anchor stem cells to the marrow matrix either directly via SDF -1 alfa or through the induction of other adhesion molecules. Treatment with plerixafor results in leukocytosis and elevations in circulating hematopoietic progenitor cells.

Genuine Medicines

Genuine Medicines

Fast Delivery

Fast Delivery

Secure Payment

Secure Payment

Best prices & offers

Best prices & offers